Practical Synthesis of Cytidine-5-Carboxamide-Modified Nucleotide Reagents |
| |
Authors: | John C. Rohloff Catherine Fowler Brian Ream Jeffrey D. Carter Greg Wardle Tim Fitzwater |
| |
Affiliation: | 1. SomaLogic Inc., Boulder, Colorado, USAjrohloff@somalogic.com;3. SomaLogic Inc., Boulder, Colorado, USA |
| |
Abstract: | Chemically-modified derivatives of cytidine, bearing a 5-(N-substituted-carboxamide) functional group, are new reagents for use in aptamer discovery via the SELEX process (Systematic Evolution of Ligands by EXponential enrichment). Herein, we disclose a practical synthesis of 5-(N-benzylcarboxamide)-2′-deoxycytidine, and the corresponding 5-(N-1-naphthylmethylcarboxamide)- and 5-(N-3-phenylpropylcarboxamide)-2′-deoxycytidine analogs, as both the suitably-protected 3′-O-cyanoethylphosphoramidite reagents (CEP; gram scale) and the 5′-O-triphosphate reagents (TPP; milligram-scale). The key step in the syntheses is a mild, palladium(0)-catalyzed carboxyamidation of an unprotected 5-iodo-cytidine. Use of the CEP reagents for solid-phase oligonucleotide synthesis was demonstrated and incorporation of the TPP reagents by KOD polymerase in a primer extension assay confirmed the utility of these reagents for SELEX. Finally, the carboxyamidation reaction was also used to prepare the nuclease-resistant sugar-variants: 5-(N-benzylcarboxamide)-2′-O-methyl-cytidine and 5-(N-3-phenylpropylcarboxamide)-2′-deoxy-2′-fluoro-cytidine. |
| |
Keywords: | Aptamer SELEX modified nucleotide cytidine-5-carboxamide |
|
|